Aurobindo Pharma calls off deal with Sandoz Inc; stock hits 10% lower circuit

This decision was taken as approval from the US Federal Trade Commission for the transaction was not obtained within anticipated timelines, the pharma company said.

from India Infoline News Service https://ift.tt/2R7WXqQ